Since the levels of the serum tumor marker (CEA, CA 724, CA 199) had small fluctuation (Fig. 5), the patient also received 8 courses of TACE, 2 courses of PEI, 1 course of RFA during this time. The gene discussed is CEACAM5; the disease is neoplasm.